読み込み中
NASDAQHealthcareMedical - Devices
最新データ
$4.19
+$0.065 · +1.58%
EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.
前日終値
$4.19
+$0.065 · +1.58%
日中の時刻はETです。市場データは遅延する場合があります。
EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.
日中レンジ
現在 $4.19
52週レンジ
現在 $4.19
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
47
適正価値
センチメント
48
まちまち
リスク
33
中程度のリスク
モメンタム
78
上昇基調
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.
日中レンジ
現在 $4.19
52週レンジ
現在 $4.19
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 7074.52万 USD | 6935.26万 USD | 6532.42万 USD | 5791.71万 USD | 5208.4万 USD |
| 売上原価 | 4065.14万 USD | 4062.72万 USD | 3893.31万 USD | 3249.19万 USD | 3030.95万 USD |
| 粗利益 | 3009.38万 USD | 2872.54万 USD | 2639.11万 USD | 2542.52万 USD | 2177.45万 USD |
| 研究開発 | 1012.82万 USD | 910.03万 USD | 821.22万 USD | 604.42万 USD | 562.39万 USD |
| 販売・一般管理 | 4517.43万 USD | 4257.97万 USD | 4028.24万 USD | 2473.05万 USD | 1965.87万 USD |
| 営業費用 | 5530.26万 USD | 5167.99万 USD | 4849.45万 USD | 3077.46万 USD | 2528.26万 USD |
| 受取利息 | 25.28万 USD | 86.1万 USD | 141.73万 USD | 42.46万 USD | 1.18万 USD |
| 支払利息 | 79.14万 USD | 25.53万 USD | 25.08万 USD | 17.66万 USD | 6.15万 USD |
| 減価償却費と償却費 | 342.66万 USD | 280.37万 USD | 208.11万 USD | 172.15万 USD | 227.06万 USD |
| 営業利益 | −2520.88万 USD | −2295.46万 USD | −2210.34万 USD | −534.95万 USD | −350.81万 USD |
| 純利益 | −2933.65万 USD | −2057.14万 USD | −2289.56万 USD | −308.25万 USD | 82.74万 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
AIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
